GlassScriptPhysician profile
Whitney K Castle
NPI 1467714246
$6,457.38
in general payments reported to CMS, 2019-2025
20 companies · $1,572 in 2025
The $1,572 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $594 · 2021: $1,190 · 2022: $680 · 2023: $669 · 2024: $1,101 · 2025: $1,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,186 · Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,185.62 |
| Food and Beverage | $1,156.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,054.67 | 2021-2025 | |
| Smith+Nephew, INC. | $1,442.45 | 2019-2025 | Collagenase Santyl |
| Kerecis Limited | $910.74 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Osiris Therapeutics INC. | $217.07 | 2019 | |
| Organogenesis INC. | $194.01 | 2019-2023 | Puraply |
| Zimmer Biomet Holdings, INC. | $130.29 | 2019 | |
| Stryker Corporation | $81.94 | 2021-2025 | Augment Injectable, Easyfuse |
| Orthofix Medical, INC. | $70.79 | 2021-2024 | Physio-Stim, Trinity Elite |
| Abbott Laboratories | $48.68 | 2023-2024 | Eterna, Proclaim |
| Bioventus LLC | $47.67 | 2019-2021 | |
| Integra Lifesciences Corporation | $40.83 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Horizon Therapeutics Plc | $35.00 | 2022-2023 | Krystexxa |
| Wright Medical Technology, INC. | $34.78 | 2019 | |
| Averitas Pharma INC. | $28.10 | 2024 | Qutenza |
| Medwest Associates | $24.24 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $21.75 | 2019 | |
| Next Science LLC | $20.11 | 2023 | Xperience, Blastx, Surgx |
| Lightbody Medical Technologies INC | $18.54 | 2024 | |
| Polynovo North America LLC | $18.45 | 2023 | |
| Osteomed LLC | $17.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Castle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.